본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Regional Health Disparities in Hypertension-Related Hospitalization of Hypertensive Patients: A Nationwide Population-Based Nested Case-Control Study
()

lee woo-ri
(Division of Cancer Management Policy)
. Regional Health Disparities in Hypertension-Related Hospitalization of Hypertensive Patients: A Nationwide Population-Based Nested Case-Control Study. INTERNATIONAL JOURNAL OF PUBLIC HEALTH. 2023-01-24; 2023; 68:1605495~. IF 4.6 (2022)
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria Kim Ho Jin
(Division of Rare and Refractory Cancer )


()
. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. LANCET NEUROLOGY. 2023-01-24; 2023; 22(3):268~282. IF 48 (2022)
Is COVID-19 induced reductions in the level of physical activity associated with increased depressive symptoms in patients with hypertension?
()

Kim Woo Rim
(Division of Cancer Management Policy)
. Is COVID-19 induced reductions in the level of physical activity associated with increased depressive symptoms in patients with hypertension?. JOURNAL OF PSYCHOSOMATIC RESEARCH. 2023-01-20; 2023; 166:111160~. IF 4.7 (2022)
A Standardized Pathology Report for Gastric Cancer: 2nd Edition
()

Kook Myeong-Cherl
(Cancer Diagnostics Branch)
. A Standardized Pathology Report for Gastric Cancer: 2nd Edition. JOURNAL OF GASTRIC CANCER. 2023-01-20; 2023; 23(1):107~145. IF 2.5 (2022)
Long-term bidirectional
association between asthma and
attention deficit hyperactivity
disorder: A big data cohort study
()

Lee Min Kyu
(Division of Cancer Early Detection)
. Long-term bidirectional association between asthma and attention deficit hyperactivity disorder: A big data cohort study. FRONTIERS IN PSYCHIATRY. 2023-01-19; 2023; :~. IF 5.435 (2021)
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry LIM MYONG CHEOL
(Rare & Pediatric Cancer Branch)


()
. Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry. JOURNAL OF GYNECOLOGIC ONCOLOGY. 2023-01-19; 2023; 34(2):e39~. IF 3.9 (2022)
Alcoholic liver disease in relation to cancer incidence and mortality: Findings from a large, matched cohort study in South Korea Oh J K
(Department of Cancer Control and Population Health)


()
. Alcoholic liver disease in relation to cancer incidence and mortality: Findings from a large, matched cohort study in South Korea. CANCER MEDICINE. 2023-01-18; 2023; 12(7):8754~8766. IF 4 (2022)
Comparison of the risks of occupational diseases, avoidable hospitalization, and all-cause deaths between firefighters and non-firefighters: A cohort study using national health insurance claims data
()

lee woo-ri
(Division of Cancer Management Policy)
. Comparison of the risks of occupational diseases, avoidable hospitalization, and all-cause deaths between firefighters and non-firefighters: A cohort study using national health insurance claims data. FRONTIERS IN PUBLIC HEALTH. 2023-01-16; 2023; 10:1070023~. IF 5.2 (2022)
Antigen-independent IL-17A production by bystander-activated CD4+IL-1R1+ cells in patients with multiple sclerosis Kim Ho Jin
(Division of Rare and Refractory Cancer )

Kim So Yeon
(Immuno-oncology Branch)
. Antigen-independent IL-17A production by bystander-activated CD4+IL-1R1+ cells in patients with multiple sclerosis. HUMAN IMMUNOLOGY. 2023-01-04; 2023; 84(3):241~246. IF 2.7 (2022)
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III-IV ovarian cancer from a randomized controlled phase III trial in Korea (KOV-HIPEC-01) Chang Yoon Jung
(Department of Cancer Control and Population Health)

Kim Ji Hyun
(Department of Obstetrics and Gynecology)
. Cost-effectiveness of hyperthermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III-IV ovarian cancer from a randomized controlled phase III trial in Korea (KOV-HIPEC-01). GYNECOLOGIC ONCOLOGY. 2023-01-04; 2023; 170:19~24. IF 4.7 (2022)